EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 25-Dec-2025 09:11 ET (25-Dec-2025 14:11 GMT/UTC)

13-Oct-2025

New way to weaken cancer cells could supercharge prostate cancer treatment

Flinders University
Peer-Reviewed Publication

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men.

Journal: Proceedings of the National Academy of Sciences
Funder: Cancer Council SA, Cancer Council NSW, Flinders Foundation, Movember Foundation, Prostate Cancer Foundation of Australia, Hospital Research Foundation, Cancer Australia, Masonic Charities Trust, Australian Research Council

13-Oct-2025

Advances in gene therapy for deafness, precision cancer surgery, and access to specialized ENT care all showcased in Indianapolis

American Academy of Otolaryngology - Head and Neck Surgery
Meeting Announcement

The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) 2025 Annual Meeting & OTO EXPO featured three prestigious named lectures that highlighted advances affecting patient care worldwide.

From cochlear gene therapy that could reverse genetic deafness to precision surgical techniques that improve cancer outcomes, and access to specialized ENT-related care, the depth of these lectures demonstrate why thousands of otolaryngologists from around the globe travel to this premier education event each year—to access the clinical education and discussions that directly impact the care they provide to patients.

13-Oct-2025

Research alert: Bioengineering breathes new life into failed cancer treatment

University of California - San Diego
Peer-Reviewed Publication

By reworking an existing protein, researchers at UC San Diego have revitalized a previously unsuccessful cancer treatment.

Journal: Molecular Cancer Therapeutics

13-Oct-2025

New lab-grown human embryo model produces blood cells

University of Cambridge
Peer-Reviewed Publication

Researchers have found a new way to produce human blood cells in the lab that mimics the process in natural embryos. Their discovery holds potential to simulate blood disorders like leukaemia, and to produce long-lasting blood stem cells for transplants.

Journal: Cell Reports
Funder: Wellcome Trust

13-Oct-2025

Identification of antralization-specific factors in peripheral blood and gastric mucosa of patients with upper gastrointestinal symptoms

Xia & He Publishing Inc.
Peer-Reviewed Publication

Antralization is considered a critical, reversible stage preceding gastric cancer. However, available biomarkers for identifying antralization are lacking. This study aimed to explore antralization-specific biomarkers in peripheral blood and gastric mucosa.

Journal: Cancer Screening and Prevention

13-Oct-2025

Breast, lung, and bladder cancer phase 3 trials led by Dana-Farber presented at ESMO Congress 2025

Dana-Farber Cancer Institute
Reports and Proceedings

Dana-Farber Cancer Institute researchers are leading four studies with important new findings in breast cancer, lung cancer, and bladder cancer at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The studies will be presented both in-person and online from October 17 to October 21.

Dana-Farber investigators will also present clinical trial results that report improved quality of life for metastatic breast cancer patients; new approaches, based on early investigations, to using blood tests to guide the treatment of kidney cancer; and new ways to analyze real-world data with artificial intelligence.

Meeting: ESMO Congress 2025

13-Oct-2025

ESMO 2025: A glimpse into the congress program

European Society for Medical Oncology
Meeting Announcement

The ESMO Congress 2025 will take place from 17-21 October in Berlin, Germany, where internationally renowned oncology experts will present cutting-edge data and engage in thought-provoking discussions covering the current advances and future directions of oncology research and care.

13-Oct-2025

Decoding the secrets of ‘chemo brain’

Virginia Tech
Peer-Reviewed Publication

Researchers offer new models for studying causes of chemo brain and point to the effects of chemotherapy drugs on the brain’s lymphatic system, which is a network of tiny vessels in the brain’s protective membranes that help remove waste and transport immune cells.

Journal: Communications Biology
Funder: NIH/National Institute on Aging, NIH/National Institute on Aging, NIH/National Cancer Institute, NIH/National Cancer Institute, NIH/National Cancer Institute, Susan G. Komen, American Cancer Society

13-Oct-2025

Singapore scientists identify markers of key stem cell populations driving colorectal cancer formation

Agency for Science, Technology and Research (A*STAR), Singapore
Peer-Reviewed Publication

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), led by an internationally recognised stem cell expert, have identified markers of two critical stem cell populations that drive colorectal cancer formation. The breakthrough study, published in Nature Cell Biology, reveals how NOX1 and NPY1R proteins mark distinct stem cell populations in different colon regions that serve as the origins of colorectal cancer, providing new targets and models for developing region-specific cancer treatments.

Journal: Nature Cell Biology

12-Oct-2025

Glue prevents complications after breast cancer surgery

KeAi Communications Co., Ltd.
Peer-Reviewed Publication

Researchers in Russia have demonstrated that the use of a latex-based tissue adhesive during axillary lymphadenectomy significantly reduces the risk of seroma and lymphorrhea, shortens hospital stay, and accelerates the initiation of adjuvant therapy.

Journal: Chinese Journal of Plastic and Reconstructive Surgery